IgA Nephropathy Market to Reach USD 99,655.4 Million by 2035, Growing at a 7.6% CAGR from 2025 to 2035, Driven by Advances in Targeted Therapies and New Treatment Developments

January 13, 2025 9:35 AM

NEWARK, DE / ACCESSWIRE / January 13, 2025 / The IgA Nephropathy Market is poised for significant growth over the forecast period from 2025 to 2035, driven by advancements in diagnostics, therapeutic innovations, and an increasing prevalence of chronic kidney disease (CKD). In 2025, the market is valued at USD 46,821.70 million, with projections estimating a substantial increase to USD 99,655.4 million by 2035, reflecting a robust CAGR of...

Read more

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

January 13, 2025 9:20 AM

CHICAGO, IL / ACCESSWIRE / January 13, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has entered into a distribution agreement with Virax Biolabs Group...

Read more

Conference Call on Year-End Report 2024

January 13, 2025 8:45 AM

GOTHENBURG, SWEDEN / ACCESSWIRE / January 13, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Invitation to attend XVIVO's conference call regarding the presentation of the Year-end Report 2024. The presentation will be held in English.Time: Tuesday, January 28, 2025, at 2.00 pm CET / 8.00 am ESTIf you wish to participate via webcast please use the link below. Via the webcast you are able to ask written questions....

Read more

Senzime Reaches Second Milestone of Masimo Collaboration with Launch of Integration to Iris Gateway

January 13, 2025 8:30 AM

UPPSALA, SWEDEN / ACCESSWIRE / January 13, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ.), a leader in precision-based patient monitoring, today announced that the company has reached a second milestone in its collaboration with Masimo through integration with the Masimo Iris® Gateway. The new solution enables automatic transfer of data between the TetraGraph system and external electronic medical records.Senzime announced the signing...

Read more

Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference

January 13, 2025 7:00 AM

CAMBRIDGE, MA / ACCESSWIRE / January 13, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced business updates and progress across its pipeline of mRNA medicines. Moderna enters 2025 with a focus on a prioritized portfolio addressing respiratory viruses, rare diseases, oncology, and latent and other viruses where there is unmet need."In 2024, we achieved $3.0 - 3.1 billion in product sales, approval of our RSV vaccine and continued to adapt our...

Read more

NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025

January 13, 2025 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced today that it is presenting at Biotech Showcase™ 2025 in San Fransisco, being held in parallel to the JP Morgan Life Sciences Conference.Event Information:EventNanoViricides Presentation at the Biotech Showcase, San FransiscoDay & DateTuesday, January 14, 2025Time, Track...

Read more

Frontage Announces Co-CEO Promotions

January 13, 2025 6:30 AM

Frontage Holdings Corporation (SEHK stock code:1521) announced on January 6 2025 that Dr. Abdul Mutlib has decided to step aside from his current role as CEO of the company to facilitate the Company's leadership succession planning and that Chief Strategy Officer Dr. Wentao Zhang and President Dr. John Lin have been promoted to Co-CEOs of the company effective today. Going forward, Dr. Mutlib will assume an advisory role as the Chief Scientific...

Read more

Genflow Biosciences PLC Announces Holding(s) in Company - 2

January 13, 2025 2:30 AM

1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW BIOSCIENCES PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obligationNameJonathan Mark SwannCity of registered office (if applicable)rickmansworthCountry of registered office (if applicable)United Kingdom4. Details of the shareholderFull name of shareholder(s) if different from the person(s) subject...

Read more

Genflow Biosciences PLC Announces Holding(s) in Company - 1

January 13, 2025 2:00 AM

1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW BIOSCIENCES PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of financial instruments3. Details of person subject to the notification obligationNamePremier Miton Group plcCity of registered office (if applicable)GUILDFORDCountry of registered office (if applicable)United Kingdom4. Details of the shareholderFull name of shareholder(s) if different from the person(s)...

Read more

1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management Changes

January 10, 2025 5:00 PM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to provide an update to its news release dated November 29, 2024 (the "Announcement") announcing its request for a management cease trade order (the "MCTO") relating to the late filing of the Company's audited financial statements, management discussion & analysis and applicable CEO and CFO...

Read more

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 10, 2025 4:15 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective January 8, 2025, the Company granted 15,000 restricted stock units (RSUs) to New Employee 1, 15,000 RSUs to New Employee 2, and 45,000 RSUs to New Employee 3.The RSUs for New Employee 1 and New Employee 2 vest over one year starting from each employee's date of hire, and the RSUs for New Employee 3 vest equally over three years, with one-third of the...

Read more

Bristol Myers Squibb Named to Dow Jones Sustainability Index North America for Second Consecutive Year

January 10, 2025 12:50 PM

Recognition underscores BMS' continued commitment to innovation, responsibility, ESG impact and growthPRINCETON, NJ / ACCESSWIRE / January 10, 2025 / Bristol Myers Squibb (NYSE:BMY) today announced that it has been named in the prestigious Dow Jones Sustainability Index (DJSI) for the second consecutive year. This recognition further validates the company's impactful progress towards and prioritization of its environmental, social and governance...

Read more

PharmD On Demand + 340B

January 10, 2025 12:35 PM

Did you know there is a channel available that can strengthen a rural hospital's financial health, improve patient care and optimize resources, all at once?That channel is the 340B Drug Pricing Program, a non-taxpayer-funded, federal program that allows eligible hospitals and clinics to purchase drugs at significantly reduced prices. While the criterion for eligibility is detailed, two key factors include not-for-profit hospitals that serve a...

Read more

Navigating the Future of Physician Practice Management - Key 2025 Trends From Black Book Surveys

January 10, 2025 9:30 AM

As the medical industry adapts to rapid regulatory changes, operational challenges, and evolving patient expectations, Black Book Research has identified critical trends driving the adoption of advanced Practice Management Software (PPMS). These insights, drawn from 33,516 validated survey responses from physician practice administrators from Q2-Q4 2024, underscore how technology is shaping the future of practice management for practices of all...

Read more

Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates

January 10, 2025 9:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the completion of the buildout of its new Good Manufacturing Practices (GMP) manufacturing facility (the "facility") within its Stony Brook, New York, headquarters and readiness to accept orders for the manufacture of LineaDNA™ IVT templates that clients can utilize for the production of mRNA clinical trial...

Read more

The Ultimate Credentialing Solution for Independent Practitioners: Transform Your Practice in 2025 With CredyApp Solo

January 10, 2025 7:30 AM

As healthcare professionals enter a new year, the focus often shifts to improving efficiency and optimizing operations. For solo practitioners, credentialing feels like an overwhelming burden, draining time and energy. WCH introduces CredyApp Solo - a revolutionary platform designed exclusively for independent healthcare providers to simplify and streamline the credentialing process.With over two decades of expertise in billing, credentialing,...

Read more

MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test

January 9, 2025 6:00 PM

HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical trials for its Multiplo® Complete Syphilis (TP/nTP) Antibody Test (Multiplo® TP/nTP), a cutting edge device that can determine active and non-active syphilis.The upcoming trials will be led by REACH Nexus at the MAP Centre for Urban Health Solutions at...

Read more

Onco-Innovations' Technology Shown in Study to Successfully Inactivate DNA Repair in Cancer, Potentially Boosting Radiation Therapy Effectiveness

January 9, 2025 4:45 PM

Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information on its exclusively-licensed technology of a new class of PNKP (Polynucleotide Kinase 3'-Phosphatase) inhibitors (the "Technology"), which has shown in a study[1] to be effective in targeting and inactivating DNA repair processes in cancer cells, thereby potentially advancing cancer treatment and, helping to pave the way for...

Read more

ClinicMind Ranked #1 for Chiropractic EHR and Practice Management in Black Book Research 2025 User Survey

January 9, 2025 4:00 PM

In the ever-evolving healthcare landscape, chiropractors and practice owners face challenges to care. These impediments include managing practice demands, meeting regulatory changes, reducing documentation challenges, and improving the patient experience. The ClinicMind platform for the full patient care cycle becomes their trusted ally, providing Chiropractic EHR and Practice Management solutions tailored to chiropractic providers' unique...

Read more

Orlando Medical Waste Disposal Company Addresses Increase in Needlestick Injuries With Key Guide

January 9, 2025 1:11 PM

With the rising concern over needlestick injuries, BioMedical Waste Solutions, a leading provider of medical waste disposal services, with locations in Orlando, FL, is pursuing education for the general public about the dangers linked with failing to dispose of medical waste, particularly needles, using the recommended methods.The CDC states around 385,000 needlestick and sharps-related injuries occur each year among healthcare workers in the...

Read more